BCG
ELV icon

BayBridge Capital Group’s Elevance Health ELV Stock Holding History

BayBridge Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-881
Closed -$458K – 93
2024
Q3 		$458K Buy
881
+53
+6% +$28.3K 0.33% 75
2024
Q2 		$449K Buy
828
+23
+3% +$12.2K 0.35% 68
2024
Q1 		$428K Buy
+805
New +$400K 0.37% 65

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BayBridge Capital Group's ELV Position: Q4 2024 in Review

BayBridge Capital Group sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 881 shares — an estimated $458K sold.

BayBridge Capital Group first reported a position in ELV in Q1 2024 and held it in 3 quarters. The position peaked at $458K in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • BayBridge Capital Group reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • BayBridge Capital Group sold 881 Elevance Health shares in Q4 2024, an estimated $458K.
  • BayBridge Capital Group first reported a position in Elevance Health in Q1 2024 and held it in 3 quarters.
  • BayBridge Capital Group's Elevance Health position peaked at $458K in Q3 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on BayBridge Capital Group's 13F filing for Q4 2024, filed 28 Jan 2025.